Your browser doesn't support javascript.
loading
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions.
Uzzan, Mathieu; Bouhnik, Yoram; Abreu, Maria; Ahmad, Harris A; Adsul, Shashi; Carlier, Hilde; Dubinsky, Marla; Germinaro, Matthew; Jairath, Vipul; Modesto, Irene; Mortensen, Eric; Narula, Neeraj; Neimark, Ezequiel; Oortwijn, Alessandra; Protic, Marijana; Rubin, David T; Oh, Young S; Wichary, Jolanta; Peyrin-Biroulet, Laurent; Reinisch, Walter.
Afiliação
  • Uzzan M; Paris Est Créteil University UPEC, Assistance Publique-Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Gastroenterology Department, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Créteil F-94010, France.
  • Bouhnik Y; Paris IBD Center, Groupe hospitalier Ambroise Paré - Hartmann 25-27 boulevard Victor Hugo, 92200 Neuilly sur Seine, France.
  • Abreu M; Crohn's & Colitis Center, Miami, FL, USA.
  • Ahmad HA; Bristol-Myers Squibb Company, Princeton, NJ, USA.
  • Adsul S; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Carlier H; Eli Lilly and Company, Global Immunology, Brussels, Belgium.
  • Dubinsky M; Susan and Leonard Feinstein IBD Center, Icahn School of Medicine, Mount Sinai, NY, USA.
  • Germinaro M; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Jairath V; Departments of Medicine, Epidemiology and Biostatsistics, Western University, London, Canada.
  • Modesto I; Pfizer Inc., Madrid, Spain.
  • Mortensen E; Regeneron, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Gastroenterology Department, Créteil, France.
  • Narula N; Department of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, ON, Canada.
  • Neimark E; AbbVie, North Chicago, IL, USA.
  • Oortwijn A; Galapagos N.V., Leiden, The Netherlands.
  • Protic M; Eli Lilly and Company, International Business Unit, Vernier/Geneva, Switzerland.
  • Rubin DT; University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL, USA.
  • Oh YS; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd, Ridgefield, CT 06877, USA.
  • Wichary J; ICON Clinical Research, Frankfurt, Germany.
  • Peyrin-Biroulet L; University of Lorraine, University Hospital of Nancy, Vandoeuvre-lès-Nancy, France.
  • Reinisch W; Medizinische Universität Wien Klinische Abt. Gastroenterologie & Hepatologie, AKH Wien Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen (CED) Währinger Gürtel 18-20, A-1090 Vienna, Austria.
J Crohns Colitis ; 17(7): 1066-1078, 2023 Jul 05.
Article em En | MEDLINE | ID: mdl-36738443
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article